Back

The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Innovations in telemedicine, robotics, and digital solutions Remote Patient Monitoring and Telehealth ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Justin Braver

Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail
Initial experience with a 5G cellular network and robotic arm-based remote echocardiographic system in an all-comers setting
Doctor Y. Liu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Use of telemedicine with artificial intelligence for patient monitoring after transcatheter aortic valve implantation with a virtual voice assistant
Doctor M. Herrero Brocal (Alicante, ES)
Abstract Slides Video
Presentation thumbnail
Remote monitoring and prioritisation for patients awaiting transcatheter aortic valve implantation safely mitigates longer waiting times
Doctor M. Kelshiker (London, GB)
Abstract Slides Video
Presentation thumbnail
Distribution of microvascular endothelial function in different clinical and non-clinical settings in the united states and china
Doctor M. Naghavi (Houston, US)
Abstract Slides
Presentation thumbnail
Metaverse-based cardiac magnetic resonance simulation to overcome claustrophobia (META-MRI): a feasibility trial
Doctor I. Skalidis (Fribourg, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Innovations in telemedicine, robotics, and digital solutions

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Cardiac rehabilitation attendance and outcomes 3 years after acute coronary syndrome (ACS): Linked national data of the SNAPSHOT ACS audit
thumbnail
Congress Presentation
Exploring the effects of a real-time cardiac telerehabilitation using wearable devices in people with coronary artery disease following a recent myocardial infarction: a randomised controlled trial
thumbnail
Congress Presentation
Digital health program for coronary artery disease: engagement, retention and remote patient symptom assessment in a randomized controlled trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources